Author

F. Yin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Biophysics· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

H. Liu· 2 shared H. Yang· 2 shared B. Kav· 1 shared B. Strodel· 1 shared C. Chen· 1 shared C. Chiang· 1 shared C. Fan· 1 shared C. Wei· 1 shared

Activity by Year

2020-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

H. Liu

Author profile →

5 papers

Recent·Most cited

A Novel Selective ERK1/2 Inhibitor, Laxiflorin B, Targets EGFR Mutation Subtypes in Non-small-cell Lung Cancer

C. Chiang, M. Zhang, J. Huang, J. Zeng, C. Chen, D. Pan, H. Yang, M. Yang, Q. Han, W. Zou, T. Xiao, Y. Zou, F. Yin, Z. Li, L. Zhu, D. Zheng

This study identifies Laxiflorin B, a novel ERK1/2 inhibitor, showing efficacy against EGFR mutant NSCLC through apoptosis induction and suppression of AREG/EREG.

bioRxiv · Jun 27, 2022Pharmacology & Toxicology

circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular cancer

P. Li, R. Song, H. Liu, M. Liu, F. Yin, S. Ma, X. Jia, X. Lu, Y. Zhong, X. Li, X. Li

This study identifies circMRPS35 as a factor promoting HCC progression and cisplatin resistance through miR-148a-3p sponging and a drug-induced peptide.

bioRxiv · Mar 24, 2021Cell Biology

Different force fields give rise to different amyloid aggregation pathways in molecular dynamics simulations

S. Samantray, F. Yin, B. Kav, B. Strodel

This study evaluates new force fields for simulating amyloid-beta peptide aggregation, finding that force field choice significantly affects aggregation pathways and that CHARMM36m performs best.

bioRxiv · Sep 9, 2020Biophysics

SARS-CoV-2 manipulates the SR-B1-mediated HDL uptake pathway for its entry

C. Wei, L. Wan, Q. Yan, X. Wang, J. Zhang, Y. Zhang, J. Sun, X. Yang, J. Gong, C. Fan, X. Yang, Y. Wang, X. Wang, J. Li, H. Yang, , H. Zhong

This study shows SARS-CoV-2 uses the SR-B1-mediated HDL uptake pathway alongside ACE2 for entry, and blocking this pathway inhibits infection.

bioRxiv · Aug 13, 2020Microbiology

Mutual regulation between GDF11 and TET2 prevents senescence of mesenchymal stem cells

J. Gao, H. Wang, J. Shen, X. Liu, X. Zhu, E. Zhao, G. Li, Y. Sun, F. Yin, Z. Liu, Y. E. Sun, H. Liu

The paper was withdrawn due to the authors no longer supporting some conclusions.

bioRxiv · Mar 30, 2020Cell Biology